The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

MassHealth is transitioning coverage for anti-obesity drugs, designating Zepbound as the preferred option starting in January 2025, with Wegovy and Saxenda being discontinued for most adult members.

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...

Nestlé released a similar announcement on September 18, 2024, revealing an entirely new line of GLP-1-friendly foods under ...

The GLP-1 drugs are "truly causing a lot of disruption for the surgeons and for the programs, and for patients," Thomas Tsai, ...

The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...

Studies are limited, but health experts say imbibing on a GLP-1 drug can carry some theoretical risks. Here are 7 things to ...

The Fortune 500 company will be adding an "On Track" badge to 26 of its Healthy Choice frozen food items in an effort to ...

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating ...

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...